今天上午，港股市场上，优必选、京城机电股份、小米集团均上涨。 4月19日，"天工Ultra"夺得全球首个人形机器人半程马拉松冠军，其研发企业是北京 人形机器人创新中心。资料显示，该创新中心由优必选、京城机电、小米机器人等机器人行业企事业单位联合组建。 A股方面，两份重磅政策文件《关于实施自由贸易试验区提升战略的意见》《上海国际金融中心进一步提升跨境金融服务便利化行动方案》备受投资者关 注，相关板块成为今天上午市场的交易主线，引发相关个股涨停潮。 上午收盘，上证指数上涨0.31%，报3301.59点；深证成指下跌0.41%，创业板指下跌0.98%。现货黄金上午继续大涨，盘中突破3490美元/盎司关口。 | 上证指数 | 深证成指 | 创业板指 | | --- | --- | --- | | 3301.59 | 9865.30 | 1925.24 | | +10.16 +0.31% | -40.23 -0.41% - - 19.08 -0.98% | | | 跌3121 | | 涨2069 | 两大政策利好成主线 近日，中共中央、国务院印发《关于实施自由贸易试验区提升战略的意见》。《意见》从增强对外贸易综合竞争力 ...

Core Viewpoint - The A-share market experienced narrow fluctuations, with the cross-border payment concept gaining significant attention, while the Hong Kong market showed a relatively weak performance, particularly in the pharmaceutical sector, highlighted by the dramatic rise of Xintai Medical's stock before its trading suspension [1][3][10]. Group 1: Market Performance - The A-share market showed overall narrow fluctuations, with the Shanghai Composite Index rising by 0.31% and the Shenzhen Component Index and ChiNext Index falling by 0.41% and 0.98%, respectively [3]. - The cross-border payment concept sector led the gains, with a peak increase of over 4%, making it the biggest highlight of the morning session [3][4]. Group 2: Xintai Medical - Xintai Medical's stock surged, with an intraday increase exceeding 100%, before being suspended with a still substantial rise of 47.19% at the time of suspension [1][10]. - The company is a significant player in the structural heart disease intervention medical device industry in China, with a product line that includes various heart defect closure devices and has a presence in over 50 countries [11]. - Xintai Medical projected a net profit of approximately 230 million to 260 million yuan for 2024, a significant increase from 152 million yuan in 2023, primarily due to a substantial rise in sales of its bioabsorbable closure devices [11]. Group 3: Related Companies - Other companies in the cross-border payment sector, such as Xincheng Technology and Kela Software, also saw significant intraday gains, with some stocks hitting the daily limit [3][4]. - The pharmaceutical sector, including companies like Weir Pharmaceuticals and Baida Group, experienced consecutive trading halts due to significant price increases, prompting risk warnings to investors [5][6][7].

Core Viewpoint - The A-share market experienced narrow fluctuations in the morning, with the cross-border payment concept seeing significant gains, becoming the highlight of the market [1][4][5]. Group 1: A-share Market Performance - The A-share market showed mixed results, with the Shanghai Composite Index up by 0.31%, while the Shenzhen Component and ChiNext Index fell by 0.41% and 0.98% respectively [4]. - Various sectors performed differently, with multi-financial, warehousing logistics, and commercial chains leading the gains, while hotel and restaurant, tourism, and engineering machinery sectors faced declines [5]. Group 2: Cross-Border Payment Concept - The cross-border payment concept surged, with the sector's index rising over 4% during the session, marking it as the biggest highlight of the A-share market [5][6]. - Notable stocks included Xinchen Technology hitting the daily limit, and Kelong Software rising over 17%, with several other stocks like Lakala and Highwei reaching gains of over 16% [5][6]. Group 3: Regulatory Developments - A recent action plan issued by the People's Bank of China and other regulatory bodies aims to enhance cross-border financial services in Shanghai, proposing 18 key measures to improve efficiency in cross-border settlements and services [6]. - The plan emphasizes enhancing the functionality and global coverage of the Cross-Border Interbank Payment System (CIPS), encouraging more banks to join and expand its network [6]. Group 4: Hong Kong Market Performance - The Hong Kong market showed a relatively subdued performance, with the pharmaceutical sector being a notable exception, particularly with Xintai Medical experiencing a surge of over 100% before a significant pullback [2][16]. - Xintai Medical's stock was suspended after reaching a peak increase of 47.19%, highlighting the volatility in the market [2][16]. Group 5: Company-Specific Developments - Xintai Medical is a leading provider in the structural heart disease intervention medical device industry in China, with a projected net profit increase for 2024, expected to be between 230 million to 260 million yuan, compared to 152 million yuan in 2023 [17]. - The company has a diverse product line aimed at various heart conditions, with products sold in over 50 countries and regions [17]. Group 6: Stock Trading Risks - Several companies, including Baoshui Technology and Weir Pharmaceutical, have issued risk warnings due to significant stock price fluctuations, with Baoshui Technology's stock price deviating by over 20% in recent trading days [10][11][12]. - These companies have urged investors to exercise caution and make rational investment decisions in light of the market volatility [10][11][12].

Group 1 - The People's Bank of China and other authorities have issued a plan to enhance cross-border financial services in Shanghai, aiming to expand the coverage of the Cross-Border Interbank Payment System (CIPS) [1] - As of the end of December 2024, CIPS is expected to cover 185 countries and regions globally, with cross-border RMB payment amounts reaching 175 trillion yuan, a year-on-year increase of 43% [1] - The RMB has become the third-largest trade financing currency globally, indicating its growing importance in international trade [1] Group 2 - The ongoing tariff war is pushing China to accelerate the development of a settlement system using RMB to counter the dominance of the US dollar under the SWIFT framework [2] - The escalation of the tariff war and risks of global trade decoupling are expected to speed up CIPS development, leading to increased demand for upgrades in banking IT systems [2] Group 3 - Shenzhou Information has reported that it possesses technical reserves related to CIPS and has already implemented projects in cross-border and foreign currency systems [3] - Highgreat has indicated that its solutions in the RMB payment sector can assist clients in implementing various cross-border payment systems, including CIPS and SWIFT [3]

Group 1 - The A-share market saw all three major indices open lower but recover, with cross-border payment concept stocks showing significant activity, particularly the Zhongzheng Financial Technology Theme Index which rose over 2% [1] - The Financial Technology ETF (516860) increased by over 2% during trading, with a latest price of 1.17 yuan and a trading volume exceeding 37 million yuan, indicating a premium in intraday trading [1] - The People's Bank of China and six other departments recently issued guidelines to promote and regulate the cross-border flow of financial data, which is expected to create growth opportunities in the financial IT sector [1] Group 2 - The Financial Technology ETF closely tracks the Zhongzheng Financial Technology Theme Index, which includes 57 constituent stocks across the electronic and non-bank financial sectors, reflecting a comprehensive coverage of the financial technology industry [2] - The average R&D investment of the constituent stocks is over 15% for 2024, surpassing the average of the A-share technology sector, indicating a strong commitment to innovation [2] - As of April 2025, the index's price-to-earnings ratio (TTM) is 45 times, placing it in the top 30% historically, which provides a favorable valuation margin [2]

中国北京市朝阳区建国路 77 号华贸中心 3 号写字楼 34 层邮政编码 100025 电话:(86-10)5809-1000 传真:(86-10)5809-1100 北京市竞天公诚律师事务所 关于高伟达软件股份有限公司 2024 年年度股东大会的 法律意见书 致：高伟达软件股份有限公司 北京市竞天公诚律师事务所（以下简称"本所"）受高伟达软件股份有限公司 （以下简称"高伟达"或"公司"）委托，委派律师出席高伟达 2024 年年度股东大 会（以下简称"本次股东大会"），并根据《中华人民共和国证券法》（以下简称"《证 券法》"）、《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司股东 会规则》（以下简称"《股东会规则》"）等法律法规、规范性文件及现行有效的 《高伟达软件股份有限公司章程》（以下简称"《公司章程》"）的有关规定，出具 本法律意见书。 本所律师按照《股东会规则》的要求对高伟达本次股东大会的合法、合规、 真实、有效进行了充分的核查验证，保证本法律意见书不存在虚假、误导性陈述 及重大遗漏，并对本法律意见书的真实性、准确性、完整性承担相应的法律责任。 本法律意见书仅供高伟达为本次股东大会之目的 ...

数字货币板块持续走高，中油资本（000617）涨停，海联金汇（002537）、飞天诚信（300386）此前封 板,四方精创（300468）、拉卡拉（300773）、新国都（300130）涨超10%，华峰超纤（300180）、雄 帝科技（300546）、高伟达（300465）、京北方（002987）、中亦科技（301208）等跟涨。 暗盘资金正涌入这些股票，点击速看>>> ...

暗盘资金正涌入这些股票，点击速看>>> 跨境支付(CIPS)板块走高，青岛金王（002094）、中亦科技（301208）涨停，中油资本（000617）此前 封板，华峰超纤（300180）、新国都（300130）、艾融软件涨超10%，四方精创（300468）、拉卡拉 （300773）、京北方（002987）、高伟达（300465）、小商品城（600415）等跟涨。 ...

Company Overview - Gao Weida Software Co., Ltd. is a publicly listed company on the Shenzhen Stock Exchange (stock code: 300465), established in 1998, focusing on providing comprehensive, professional, and continuous technology services for financial institutions [1] - The company is recognized as a leading provider of comprehensive solutions that drive the digital and intelligent transformation of the financial industry in China [1] Stock Performance - As of April 7, Gao Weida's stock hit the daily limit down, having declined by 33.95% year-to-date [1] - The stock's performance reflects broader market trends, with the Huashang Zhongzheng Financial Technology Theme ETF, managed by Chen Jianhua, entering Gao Weida's top ten shareholders with a holding ratio of 0.58% [1][2] Fund Performance - The Huashang Zhongzheng Financial Technology Theme ETF has reported a year-to-date return of -0.64%, ranking 2070 out of 3442 in its category [1][2] - The fund manager, Chen Jianhua, has extensive experience in managing various funds within the financial technology sector [3][4] Fund Manager Background - Chen Jianhua holds a master's degree and has been with Huashang Fund Management Co., Ltd. since August 2007, serving in various roles including assistant analyst and fund manager [3][4] - His management experience includes overseeing multiple funds, with a cumulative tenure of over 12 years [4]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report emphasizes the importance of self-reliance in technology due to escalating global trade tensions, highlighting the urgency for core technology products to be self-sufficient [5][12] - National fiscal support is expected to accelerate the implementation of key projects and policies, particularly in the realm of domestic innovation and technology [6][13] - Domestic software and hardware are transitioning from being merely "usable" to "user-friendly," with an anticipated acceleration in replacement cycles [7][14] Summary by Sections Market Review - During the week of March 31 to April 3, 2025, the CSI 300 index fell by 1.37%, while the computer index decreased by 1.87% [4][16] Investment Opportunities - The report suggests that with changes in the global trade environment, domestic software and hardware are on the rise, and the pace of replacement is expected to accelerate. Recommended companies include: - For domestic computing power: Haiguang Information, Zhongke Shuguang, and Shenzhou Digital - For the innovation and creation sector: Kingsoft Office, Dameng Database, Taiji Co., and others [8][15] Industry Dynamics - The report notes significant developments in the industry, including the upcoming release of Alibaba's new model Qwen3 and OpenAI's completion of a $40 billion financing round, which values the company at $300 billion [22][28]